MITO

Stealth BioTherapeutics Corp. ADS

Delisted

MITO was delisted on the 15th of November, 2022.

0 hedge funds and large institutions have $0 invested in Stealth BioTherapeutics Corp. ADS in 2022 Q4 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
Holders Change
-12
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
12
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
IC
1
Ikarian Capital
Texas
-$134K -435,516 Closed
BBHC
2
Brown Brothers Harriman & Co
New York
-$54K -174,999 Closed
Renaissance Technologies
3
Renaissance Technologies
New York
-$30K -96,944 Closed
Geode Capital Management
4
Geode Capital Management
Massachusetts
-$15K -48,791 Closed
BFM
5
Boothbay Fund Management
New York
-$14K -43,790 Closed
Susquehanna International Group
6
Susquehanna International Group
Pennsylvania
-$10K -30,991 Closed
Envestnet Asset Management
7
Envestnet Asset Management
Illinois
-$7K -23,248 Closed
CAPTRUST Financial Advisors
8
CAPTRUST Financial Advisors
North Carolina
-$5K -15,000 Closed
Two Sigma Advisers
9
Two Sigma Advisers
New York
-$4K -13,700 Closed
Osaic Holdings
10
Osaic Holdings
Arizona
-$3K -10,124 Closed
AA
11
AlphaMark Advisors
Kentucky
-$1K -2,306 Closed